AJTMH Transactions of the Royal Society of Tropical Medicine and Hygiene
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 54(3), 1996, pp. 265-270
Copyright © 1996 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yole, D. S.
Right arrow Articles by Wilson, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yole, D. S.
Right arrow Articles by Wilson, R. A.

Protection Against Schistosoma mansoni and Associated Immune Responses Induced in the Vervet Monkey Cercopithecus aethiops by the Irradiated Cercaria Vaccine

Dorcas S. Yole, Graham D. F. Reid AND R. Alan Wilson
Institute for Primate Research, Karen, Nairobi, Kenya; Department of Biology, The University of York, York, United Kingdom

The efficacy of the radiation-attenuated schistosome vaccine in eliciting protective immunity was investigated in the vervet Cercopithecus aethiops. Three groups of test animals received one, three, or five exposures to 5,000–9,000 cercariae attenuated with 30 krad of gamma radiation from a 137Cs source, while a fourth group served as challenge controls. After a single vaccination, no statistically significant protection was found; after three vaccinations it reached its highest peak (48%) and five exposures resulted in reduced protection (39%). Examination of immunologic parameters supported these findings, with proliferative responses of peripheral blood lymphocytes being greatest in the group vaccinated three times. Specific immunoglobulin G (IgG) levels also peaked after three vaccinations, with clear evidence of a reduction after the fourth and fifth exposures. There was a clear correlation (r = 0.66) between the antibody level at the time of challenge and the protection observed in individual vervets. These data demonstrate that protective immunity to Schistosoma mansoni can be achieved with the attenuated vaccine in a highly susceptible nonhuman primate (i.e., 82% maturation of penetrant cercariae was recorded in challenge control animals in this study). However, they also indicate that there is a ceiling to this protection. Furthermore, increasing the number of vaccinations beyond a certain point, instead of boosting protection may cause it to diminish, possibly due to the induction of immunoregulatory mechanisms.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
T. M. Kariuki, G. J. Van Dam, A. M. Deelder, I. O. Farah, D. S. Yole, R. A. Wilson, and P. S. Coulson
Previous or Ongoing Schistosome Infections Do Not Compromise the Efficacy of the Attenuated Cercaria Vaccine
Infect. Immun., July 1, 2006; 74(7): 3979 - 3986.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Society of Tropical Medicine and Hygiene.